Related Experiment Videos
Acute hemodynamic effects of celiprolol.
R M Donaldson1, L A Williams, E H Lee
1National Heart Hospital, London, England.
The American Journal of Cardiology
|February 10, 1988
Summary
Celiprolol, a beta 1-selective antagonist, shows promise for treating heart conditions without negative cardiac effects. This study investigated its acute impact on cardiac hemodynamics in patients already taking atenolol.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Beta-adrenoceptor antagonists are vital for ischemic heart disease and hypertension.
- Limitations include bronchoconstriction, vasoconstriction, and negative inotropic effects.
- Celiprolol exhibits beta 1-selectivity with bronchodilating and vasodilating properties, lacking cardiodepressant effects.
Purpose of the Study:
- To evaluate the acute cardiovascular effects of intravenous celiprolol.
- To assess celiprolol's impact on cardiac hemodynamics in patients pretreated with oral atenolol.
Main Methods:
- Intravenous administration of celiprolol.
- Monitoring of cardiac hemodynamics.
- Patients pretreated with oral atenolol.
Main Results:
- Acute administration of intravenous celiprolol.
- Observed effects on cardiac hemodynamics.
- Patient cohort pretreated with oral atenolol.
Conclusions:
- Celiprolol's potential as a cardiovascular therapeutic.
- Further research into celiprolol's hemodynamic profile.
- Understanding celiprolol's effects in combination therapy.